Header Logo
Last Name

You can now add alternative names! Click here to add other names that you've published under.


Search Results to Laura Hutchins

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Hutchins, Laura

Item TypeName
Academic Article Combined endocrine blockade in premenopausal breast cancer: a superior therapeutic option for adjuvant management?
Academic Article Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.
Academic Article Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
Academic Article Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer.
Academic Article Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
Academic Article Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.
Academic Article Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.
Academic Article Overexpression of HER-2/neu in uterine serous papillary cancer.
Concept Antineoplastic Agents
Concept Antineoplastic Agents, Alkylating
Concept Antineoplastic Agents, Hormonal
Academic Article Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib.
Academic Article Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literature.
Academic Article Response of metastatic mucosal melanoma to immunotherapy: It can get worse before it gets better.
Academic Article Managing Expectations in the Transition to Proof of Concept Studies.
Academic Article Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
Academic Article Do checkpoint inhibitors rely on gut microbiota to fight cancer?
Academic Article Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
Academic Article Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.

Search Criteria
  • Antineoplastic Agents